GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Transcriptomic Changes Linked to Brain Regeneration Identified in Zebrafish Study

by GOAI
Share To

Researchers have identified key transcriptomic changes associated with brain regeneration in zebrafish, a species known for its extraordinary regenerative abilities. The study, conducted by Bhasin, Kaushal, and Srivastava and published in the *Journal of Translational Medicine*, provides new insights into the molecular mechanisms underlying this process. Zebrafish serve as a widely recognized model organism for studying tissue regeneration due to their capacity to repair and regrow damaged brain tissue, a capability not observed in mammals.

The research highlights the complex gene expression patterns that occur during the regeneration process. By analyzing transcriptomic data, the team documented significant shifts in gene activity linked to cellular repair, neurogenesis, and inflammation regulation. These findings offer a detailed view of how zebrafish brains respond to injury at the molecular level. The study’s results contribute to a growing body of knowledge aimed at understanding regenerative biology and may inform future studies on potential applications for human medicine.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top